Decisions on pharmacogenomic tests in the USA and Germany (2011)
Authors
Abstract
With the increase in molecular genetic understanding of disease, diagnostic test development and availability are growing rapidly. This study investigated oncologists' decision making on using pharmacogenomic tests for cancer treatment and examined cross-cultural differences between the USA and Germany.
Bibliographic entry
Wegwarth, O., Day, R. W., & Gigerenzer, G. (2011). Decisions on pharmacogenomic tests in the USA and Germany. Journal of Evaluation in Clinical Practice, 17, 228-235. doi:10.1111/j.1365-2753.2010.01426.x (Full text)
Miscellaneous
| Publication year | 2011 | |
|---|---|---|
| Document type: | Article | |
| Publication status: | Published | |
| External URL: | http://library.mpib-berlin.mpg.de/ft/ow/OW_Decisions_2011.pdf View | |
| Categories: | Health | |
| Keywords: | diagnosticsheuristics in medicinejudgment analysismedical decision makingoncologypharmacogenomics |